[Correspondence] Consequence of prioritising pathogens for global antibiotic research
We agree with The Lancet Infectious Diseases that any prioritisation exercise to select important organisms for new antibiotic research inevitably leads to a decrease in emphasis for other pathogens omitted from the selection, such as mycobacteria.1 Restricting the list to promote research on antibacterial agents might be justifiable; however, Mycobacterium tuberculosis is a bacterium. It is insufficient to state that drug resistant tuberculosis “is already a globally established priority for which innovative new treatments are urgently needed”.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Ibrahim Abubakar, Helen Strain Tags: Correspondence Source Type: research